Status:
UNKNOWN
Immunophenotyping of Acute b Cell Lymphoblstic Leukemia
Lead Sponsor:
South Egypt Cancer Institute
Conditions:
Acute Leukemia
Eligibility:
All Genders
12-80 years
Brief Summary
To study the immunophenotyping pattern of acute B lymphoblastic leukemia in south Egypt Cancer Institute iand its correlation with disease outcome
Detailed Description
study the immunophenotyping pattern of acute B lymphoblastic leukemia in south Egypt Cancer Institute from 2009 -2019 and its correlation with disease outcome
Eligibility Criteria
Inclusion
- New cases admitted to SECI Who didn't receive treatment.Age above 1 years old.
Exclusion
- Cases who received treatment Patients below 1 years old.Patients diagnosed as AML or T-ALL
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04084327
Start Date
September 1 2019
End Date
December 1 2022
Last Update
September 10 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.